Showing 1 - 2 results of 2, čas poizvedbe: 0.09s Refine Results
  1. 1
    Evaluation of cell death mechanisms induced by the vascular disrupting agent OXi4503 during a phase I clinical trial

    Evaluation of cell death mechanisms induced by the vascular disrupting agent OXi4503 during a phase I clinical trial od Cummings, J, Zweifel, M, Smith, N, Ross, P, Peters, J, Rustin, G, Price, P, Middleton, MR, Ward, T, Dive, C

    Izdano 2012
    Journal article
  2. 2
    Evaluation of cell death mechanisms induced by the vascular disrupting agent OXi4503 during a phase I clinical trial.

    Evaluation of cell death mechanisms induced by the vascular disrupting agent OXi4503 during a phase I clinical trial. od Cummings, J, Zweifel, M, Smith, N, Ross, P, Peters, J, Rustin, G, Price, P, Middleton, MR, Ward, T, Dive, C

    Izdano 2012
    Journal article

Iskalna orodja: